Product Information
NUVARING VAGINAL RING is a brand product labeled by Organon LLC, priced at $155.7028 per EA under NDC 78206014603. Its NADAC has been published 258 times since Sep 15, 2021.
FDA first approved this application on Oct 3, 2001. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the etonogestrel and ethinyl estradiol market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.015; .12 mg/d; mg/d
Manufacturer
Organon LLCNDC
78206014603
Classification
Brand
Dosage Form
INSERT, EXTENDED RELEASE
Route
VAGINAL
Effective Date
7/22/2026
Active Ingredients
ETHINYL ESTRADIOL; ETONOGESTRELApproval Type
New Drug (NDA)
FDA Application
NDA021187FDA Approved
10/3/2001
TE Code
AB
On Market Since
6/1/2021
Price Statistics
The NADAC for NUVARING VAGINAL RING has been published 258 times since Sep 15, 2021, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $155.7028 per EA |
|---|---|
| All-time high | $156.1904 (Sep 14, 2022) |
| All-time low | $155.6597 (Sep 21, 2022) |
| 52-week high | $155.9074 |
| 52-week low | $155.7028 |
| Median price | $155.8925 |
| Average price | $155.9336 |
| Largest weekly change | -0.3% (Sep 21, 2022) |
| Weeks tracked | 258 |
| Tracking since | Sep 15, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 70% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NUVARING VAGINAL RING?
The current National Average Drug Acquisition Cost (NADAC) for NUVARING VAGINAL RING, manufactured by Organon LLC, is $155.7028 per EA (NDC 78206014603), effective Aug 19, 2026.
How has the price of NUVARING VAGINAL RING changed over time?
Over the history we have for it, the NADAC for NUVARING VAGINAL RING has held within roughly two percent of its current level. It has been tracked across 258 weekly CMS publications since Sep 15, 2021.
What are the highest and lowest recorded NADAC prices for NUVARING VAGINAL RING?
Since Sep 15, 2021, the NADAC for NUVARING VAGINAL RING has ranged from a low of $155.6597 (Sep 21, 2022) to a high of $156.1904 (Sep 14, 2022), with a median of $155.8925 per EA.
Are there cheaper alternatives to NUVARING VAGINAL RING?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ETONOGESTREL-EE VAGINAL RING, is $47.1716 per EA — about 70% below NUVARING VAGINAL RING.
Who manufactures NUVARING VAGINAL RING?
NUVARING VAGINAL RING (NDC 78206014603) is labeled by Organon LLC, and CMS classifies it as a brand product.